Biocept Inc (NASDAQ:BIOC)

0.751
Delayed Data
As of Nov 30
 0.00 / 0.00%
Today’s Change
0.70
Today|||52-Week Range
4.40
-79.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues822.2K761.6K859.5K1.0M
 
 
 
 
 
Cost of Goods Sold2.5M2.3M2.2M2.4M
 
 
 
 
 
Depreciation And Amortization177.4K223.2K220.5K184.3K
 
 
 
 
 
 
Operating ExpensesGross Income-1.9M-1.7M-1.6M-1.6M
 
 
 
 
 
General Expenses4.2M4.3M4.4M4.3M
 
 
 
 
 
Research And Development1.0M1.1M1.3M1.2M
 
 
 
 
 
Total Operating Expenses6.9M6.8M6.8M6.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.0M-6.0M-5.9M-5.9M
 
 
 
 
 
Interest Expense On Debt84.2K63.8K80.3K62.0K
 
 
 
 
 
Other Expenses-30.0K24.0K6.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.2M-6.0M-6.0M-5.9M
 
 
 
 
 
Income Taxes0.000.00-1.1K0.00
 
 
Preferred Dividend0.00-636.4K0.00-99.7K
 
 
 
Net Income-6.2M-6.0M-6.0M-5.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.3M2.8M4.2M9.8M
 
 
 
 
 
Shares To Calculate EPS Diluted2.3M2.8M4.2M9.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.70-$2.42-$1.43-$0.61
 
 
 
 
 
EPS Diluted-$2.70-$2.42-$1.43-$0.61